Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Sarcopenia Treatment Pipeline Drugs Market Report Overview
Sarcopenia is a progressive and generalized skeletal muscle disorder involving the accelerated loss of muscle mass and function, with a risk of adverse outcomes such as physical disability, poor quality of life, and death. The etiology of sarcopenia is multi-factorial in many older people. Therefore, it may not be possible to characterize each individual as having a primary or secondary condition. Multiple risk factors and mechanisms such as a neurodegenerative process, reduction in anabolic hormone productions or sensitivity, dysregulation of cytokine secretions, and modification in the inflammatory state contribute to the development of sarcopenia. There has been considerable expansion for R&D activity in sarcopenia since its recognition as an independent condition in the International Classification of Disease, 10th revision, Clinical Modification (ICD-10-CM) in 2016.
The Sarcopenia marketed and pipeline drugs assessment report provides a data-driven overview of the current and future competitive landscape in Sarcopenia therapeutics. The report will also help to develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Sarcopenia Marketed and Pipeline Drugs Market Overview by Mechanism of Action
The major mechanism of action segments in the Sarcopenia marketed and pipeline drugs market are receptor agonist, enzyme inhibitor, protein and peptide activator, protein and peptide inhibitor, ion channel blocker, and biological factor inhibitor. Receptor agonist led the market in 2022.
Sarcopenia Marketed and Pipeline Drugs Market Analysis by Mechanism of Action, 2022 (%)
For more mechanism of action insights in the Sarcopenia marketed and pipeline drugs market, download a free report sample
Sarcopenia Marketed and Pipeline Drugs Overview by Route of Administration
The major routes of administration segments in the Sarcopenia marketed and pipeline drugs market are oral therapies, injection, and topical therapies. Oral RoA led the market in 2022.
Sarcopenia Marketed and Pipeline Drugs Market Analysis by Route of Administration, 2022 (%)
For more routes of administration insights in the Sarcopenia marketed and pipeline drugs market, download a free report sample
Sarcopenia Marketed and Pipeline Drugs Market Report Overview
Major Mechanism of Action | Receptor Agonist, Enzyme Inhibitor, Protein and Peptide Activator, Protein and Peptide Inhibitor, Ion Channel Blocker, and Biological Factor Inhibitor |
Major Route of Administration | Oral Therapies, Injection, and Topical Therapies |
Sarcopenia Marketed and Pipeline Drugs Market MoA Outlook
- Receptor Agonist
- Enzyme Inhibitor
- Protein and Peptide Activator
- Protein and Peptide Inhibitor
- Ion Channel Blocker
- Biological Factor Inhibitor
Sarcopenia Marketed and Pipeline Drugs Market RoA Outlook
- Oral Therapies
- Injection
- Topical Therapies
Scope
GlobalData’s Sarcopenia Treatment Pipeline Drugs Analysis, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Sarcopenia market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Sarcopenia market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What are the major mechanisms of action in the Sarcopenia marketed and pipeline drugs assessment market?
The major mechanism of action segments in the Sarcopenia marketed and pipeline drugs market are receptor agonist, enzyme inhibitor, protein and peptide activator, protein and peptide inhibitor, ion channel blocker, and biological factor inhibitor.
-
What are the major routes of administration in the Sarcopenia marketed and pipeline drugs assessment market?
The major routes of administration segments in the Sarcopenia marketed and pipeline drugs market are oral therapies, injection, and topical therapies.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.